CA2427560A1 - Amides d'alkynyle et leurs applications therapeutiques - Google Patents

Amides d'alkynyle et leurs applications therapeutiques Download PDF

Info

Publication number
CA2427560A1
CA2427560A1 CA002427560A CA2427560A CA2427560A1 CA 2427560 A1 CA2427560 A1 CA 2427560A1 CA 002427560 A CA002427560 A CA 002427560A CA 2427560 A CA2427560 A CA 2427560A CA 2427560 A1 CA2427560 A1 CA 2427560A1
Authority
CA
Canada
Prior art keywords
propyl
hexynamide
compound
oxoethyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002427560A
Other languages
English (en)
Other versions
CA2427560C (fr
Inventor
Youssef L. Bennani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2427560A1 publication Critical patent/CA2427560A1/fr
Application granted granted Critical
Publication of CA2427560C publication Critical patent/CA2427560C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne des composés de formule (I), nouveaux et utiles permettant de traiter la crise, la migraine et les troubles psychiatriques.
CA2427560A 2000-11-01 2001-10-31 Amides d'alkynyle et leurs applications therapeutiques Expired - Fee Related CA2427560C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70377100A 2000-11-01 2000-11-01
US09/703,771 2000-11-01
PCT/US2001/045704 WO2002036546A2 (fr) 2000-11-01 2001-10-31 Amides d'alkynyle et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
CA2427560A1 true CA2427560A1 (fr) 2002-05-10
CA2427560C CA2427560C (fr) 2010-12-07

Family

ID=24826711

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2427560A Expired - Fee Related CA2427560C (fr) 2000-11-01 2001-10-31 Amides d'alkynyle et leurs applications therapeutiques

Country Status (8)

Country Link
EP (1) EP1330429A2 (fr)
JP (1) JP4115835B2 (fr)
AU (1) AU2002228726A1 (fr)
CA (1) CA2427560C (fr)
MX (1) MXPA03003926A (fr)
PE (1) PE20020575A1 (fr)
UY (1) UY26997A1 (fr)
WO (1) WO2002036546A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682104A2 (fr) * 2003-11-12 2006-07-26 Nps Pharmaceuticals, Inc. Traitement de la migraine comportant des composes d'isovaleramide et des agonistes de la serotonine
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents

Also Published As

Publication number Publication date
JP4115835B2 (ja) 2008-07-09
PE20020575A1 (es) 2002-06-25
AU2002228726A1 (en) 2002-05-15
WO2002036546A3 (fr) 2002-10-10
MXPA03003926A (es) 2004-05-24
CA2427560C (fr) 2010-12-07
WO2002036546A2 (fr) 2002-05-10
EP1330429A2 (fr) 2003-07-30
JP2004532804A (ja) 2004-10-28
UY26997A1 (es) 2002-07-31

Similar Documents

Publication Publication Date Title
CA2400916A1 (fr) Derives d'aminoadamantane convenant comme agents therapeutiques
CA2565852C (fr) Derives de phenol et de thiophenol 3- ou 4-monosubstitues utiles en tant que ligands h3
CA2599890A1 (fr) Derives de pyridine substitues
IS1959B (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
HUP0401086A2 (hu) 4-[(Fenil-piperazinil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, szorongás vagy gasztrointesztinális zavarok kezelésére szolgáló gyógyszerkészítmények előállítására és eljárás a vegyületek előállítására
NO944370D0 (no) Gamma-aminosyre- og L-glutaminsyreanaloger for behandling av anfall
CA2393352A1 (fr) Derives d'adamantane
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
MEP12508A (en) Derivatives of n-/phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
AU2388697A (en) 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
AU2002239463A1 (en) Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indoles as 5ht2c antagonists
CA2665476A1 (fr) Composes heterocycliques azotes bicycliques pour une utilisation en tant qu'inhibiteurs de stearoyl-coa-desaturase
ATE384698T1 (de) Therapeutische piperazin-derivate für die behandlung von schmerzen
HRP20110805T1 (hr) Homo- i heterociklički spojevi prikladni kao cetp inhibitori
CA2427560A1 (fr) Amides d'alkynyle et leurs applications therapeutiques
DK1942106T3 (da) Terapeutiske midler, der kan anvendes til behandling af smerte
NO954542D0 (no) 1-Arylcykloalkylsulfider, -sulfoksyder og sulfoner for behandling av depresjon, angst og Parkinson's sykdom
CA2483345A1 (fr) Aralkylsulfonamides d'imidazolinylmethyle
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
KR880007495A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 신경변성 질환의 치료에 있어서의 그들의 용도
DE69925160D1 (de) Arylpiperidin- und aryl-1,2,5,6-tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
GB9801501D0 (en) Chemical compounds - II
JPWO2020086816A5 (fr)
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
DE60325630D1 (de) Spirocyclopropyl-amide und -säuren und ihre therapeutischen anwendungen

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed